Cloud-based bioprocess development

Evaluate your bio clones, strains, and viral constructs with scalable flexibility using our advanced cell culture bioreactors. Our platform ensures efficient clone screening systems for optimal performance.

Accelerate timelines, optimize performance, and reduce risks in bringing biotherapeutics to market with our upstream process development services and advanced bioreactor technology. By focusing on cell culture media optimization and development, we can help ensure your experiments deliver efficient and reproducible outcomes.

Assess your process in scale-down bioreactors that allow for increased model curvature and variables in your process DOEs.

Scaling a bioprocess from R&D to manufacturing is challenging. Bioprocess modeling and simulation enables precise control over process conditions, improving efficiency and reducing variability. Our services offer a bioprocess digital twin approach to streamline development, leveraging advanced modeling to simulate and optimize conditions before running costly experiments.

Gain access to Culture bioreactors when you need rapid overflow experimental capacity.

Culture enables synthetic biology companies to screen strains and optimize fermentation processes without having to invest time and money in building out internal capacity.

Culture accelerates and de-risks process development, process characterization, material generation, and modeling for protein therapeutics in our cloud-connected bioreactor facility. By providing scalable protein therapeutic production solutions and efficient protein expression systems, we empower biotech researchers, pharmaceutical teams, and startups to rapidly optimize their processes and achieve consistent results. With Culture, you gain access to advanced tools and expertise that streamline upstream therapeutics.

Culture accelerates and de-risks upstream process development for viral vectors by parallelizing experiments to reduce program bottlenecks.